ScholarIQanswers from OpenAlex

Albumin-Consolidated AIEgens for Boosting Glioma and Cerebrovascular NIR-II Fluorescence Imaging

PaperCitations, authors & open-access status

Albumin-Consolidated AIEgens for Boosting Glioma and Cerebrovascular NIR-II Fluorescence Imaging is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Albumin-Consolidated AIEgens for Boosting Glioma and Cerebrovascular NIR-II Fluorescence Imaging have?

ScholarIQcitation count

Albumin-Consolidated AIEgens for Boosting Glioma and Cerebrovascular NIR-II Fluorescence Imaging has 53 citations in the OpenAlex counts ScholarIQ stores.

When was Albumin-Consolidated AIEgens for Boosting Glioma and Cerebrovascular NIR-II Fluorescence Imaging published?

ScholarIQyear

Albumin-Consolidated AIEgens for Boosting Glioma and Cerebrovascular NIR-II Fluorescence Imaging has 2022 year in the ScholarIQ index.

What is the open-access status of Albumin-Consolidated AIEgens for Boosting Glioma and Cerebrovascular NIR-II Fluorescence Imaging?

ScholarIQoa status

Albumin-Consolidated AIEgens for Boosting Glioma and Cerebrovascular NIR-II Fluorescence Imaging has closed oa status in the ScholarIQ index.

What is the DOI of Albumin-Consolidated AIEgens for Boosting Glioma and Cerebrovascular NIR-II Fluorescence Imaging?

ScholarIQdoi

The DOI for Albumin-Consolidated AIEgens for Boosting Glioma and Cerebrovascular NIR-II Fluorescence Imaging is on the source record.

What is the PMID of Albumin-Consolidated AIEgens for Boosting Glioma and Cerebrovascular NIR-II Fluorescence Imaging?

ScholarIQpmid

The PMID for Albumin-Consolidated AIEgens for Boosting Glioma and Cerebrovascular NIR-II Fluorescence Imaging is on the source record.

What is the OpenAlex record for Albumin-Consolidated AIEgens for Boosting Glioma and Cerebrovascular NIR-II Fluorescence Imaging?

ScholarIQopenalex

The OpenAlex for Albumin-Consolidated AIEgens for Boosting Glioma and Cerebrovascular NIR-II Fluorescence Imaging is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial